ClinicalTrials.Veeva

Menu

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

New York University (NYU) logo

New York University (NYU)

Status and phase

Enrolling
Phase 4

Conditions

Human Immunodeficiency Virus (HIV)
Smoking Cessation

Treatments

Behavioral: Peer Mentoring
Behavioral: Skills-based Text Messaging
Drug: Combination NRT
Behavioral: Motivational Interviewing (MI) Counseling

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06598397
CA268932

Details and patient eligibility

About

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Full description

This study will utilize Multiphase Optimization Strategy (MOST) to optimize a smoking cessation treatment for HIV clinical care by directly targeting patient barriers to quitting and clinical care barriers to reaching and effectively treating a broad heterogeneous population of smokers living with HIV. The four intervention components will be aimed at barriers to quitting among smokers living with HIV and include Motivational Interviewing; Peer Mentoring; Text-messaging; Combination Nicotine Replacement Therapy. These components have shown promise in research but are under-utilized to help smokers living with HIV quit and have not been tested in an optimization trial. This study will also incorporate data to evaluate the fidelity, acceptability and feasibility of the interventions in the HIV clinical care context in order to identify the most cost-effective, sustainable and scalable tobacco treatment package for the care environment.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Status as HIV+
  • Age 18 or older
  • Currently smokes ≥ 5 CPD, on average, in past month
  • Positive for salivary cotinine
  • Able to understand the nature of the study and the consenting process
  • Is engaged in HIV clinical care
  • Living in larger NYC metropolitan area currently and for the next 6-8 months

Exclusion criteria

  • Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy
  • Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)
  • Currently participating in a smoking cessation program
  • Pregnant or nursing and plans to be in next 6 months
  • Has schizophrenia/schizo-affective disorder
  • Does not have a functioning mobile phone that can receive text messages

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

500 participants in 16 patient groups

Condition 1
No Intervention group
Description:
Participants will receive the Core Component.
Condition 2
Experimental group
Description:
Participants will receive the Core Component and Combination-NRT intervention.
Treatment:
Drug: Combination NRT
Condition 3
Experimental group
Description:
Participants will receive the Core Component and Text Messaging intervention.
Treatment:
Behavioral: Skills-based Text Messaging
Condition 4
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT and Text Messaging interventions.
Treatment:
Drug: Combination NRT
Behavioral: Skills-based Text Messaging
Condition 5
Experimental group
Description:
Participants will receive the Core Component and Peer Mentoring intervention.
Treatment:
Behavioral: Peer Mentoring
Condition 6
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT and Peer Mentoring interventions.
Treatment:
Drug: Combination NRT
Behavioral: Peer Mentoring
Condition 7
Experimental group
Description:
Participants will receive the Core Component as well as the Text Messaging and Peer Mentoring interventions.
Treatment:
Behavioral: Skills-based Text Messaging
Behavioral: Peer Mentoring
Condition 8
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Peer Mentoring interventions.
Treatment:
Drug: Combination NRT
Behavioral: Skills-based Text Messaging
Behavioral: Peer Mentoring
Condition 9
Experimental group
Description:
Participants will receive the Core Component and Motivational Interviewing Counseling intervention.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Condition 10
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Drug: Combination NRT
Condition 11
Experimental group
Description:
Participants will receive the Core Component as well as the Text Messaging and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Behavioral: Skills-based Text Messaging
Condition 12
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Drug: Combination NRT
Behavioral: Skills-based Text Messaging
Condition 13
Experimental group
Description:
Participants will receive the Core Component as well as the Peer Mentoring and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Behavioral: Peer Mentoring
Condition 14
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT, Peer Mentoring and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Drug: Combination NRT
Behavioral: Peer Mentoring
Condition 15
Experimental group
Description:
Participants will receive the Core Component as well as the Text Messaging, Peer Mentoring and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Behavioral: Skills-based Text Messaging
Behavioral: Peer Mentoring
Condition 16
Experimental group
Description:
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging, Peer Mentoring, and Motivational Interview Counseling interventions.
Treatment:
Behavioral: Motivational Interviewing (MI) Counseling
Drug: Combination NRT
Behavioral: Skills-based Text Messaging
Behavioral: Peer Mentoring

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Cantrell, DrPH, MPA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems